JP2008521488A5 - - Google Patents

Download PDF

Info

Publication number
JP2008521488A5
JP2008521488A5 JP2007543080A JP2007543080A JP2008521488A5 JP 2008521488 A5 JP2008521488 A5 JP 2008521488A5 JP 2007543080 A JP2007543080 A JP 2007543080A JP 2007543080 A JP2007543080 A JP 2007543080A JP 2008521488 A5 JP2008521488 A5 JP 2008521488A5
Authority
JP
Japan
Prior art keywords
spray
nasal
olopatadine
formulation
span
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007543080A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008521488A (ja
JP5068172B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/039268 external-priority patent/WO2006057769A2/en
Publication of JP2008521488A publication Critical patent/JP2008521488A/ja
Publication of JP2008521488A5 publication Critical patent/JP2008521488A5/ja
Application granted granted Critical
Publication of JP5068172B2 publication Critical patent/JP5068172B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007543080A 2004-11-24 2005-10-31 鼻に噴霧を噴射する方法 Expired - Lifetime JP5068172B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63088604P 2004-11-24 2004-11-24
US60/630,886 2004-11-24
PCT/US2005/039268 WO2006057769A2 (en) 2004-11-24 2005-10-31 Method of delivering nasal spray

Publications (3)

Publication Number Publication Date
JP2008521488A JP2008521488A (ja) 2008-06-26
JP2008521488A5 true JP2008521488A5 (enExample) 2008-11-13
JP5068172B2 JP5068172B2 (ja) 2012-11-07

Family

ID=36498400

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007543080A Expired - Lifetime JP5068172B2 (ja) 2004-11-24 2005-10-31 鼻に噴霧を噴射する方法

Country Status (19)

Country Link
US (3) US20060110328A1 (enExample)
EP (1) EP1814538B1 (enExample)
JP (1) JP5068172B2 (enExample)
KR (1) KR101158603B1 (enExample)
CN (2) CN103860540A (enExample)
AT (1) ATE443516T1 (enExample)
AU (1) AU2005309951B2 (enExample)
BR (1) BRPI0518283A2 (enExample)
CA (1) CA2586553C (enExample)
CY (1) CY1110528T1 (enExample)
DE (1) DE602005016833D1 (enExample)
DK (1) DK1814538T3 (enExample)
ES (1) ES2331619T3 (enExample)
MX (1) MX2007005845A (enExample)
PL (1) PL1814538T3 (enExample)
PT (1) PT1814538E (enExample)
SI (1) SI1814538T1 (enExample)
WO (1) WO2006057769A2 (enExample)
ZA (1) ZA200704139B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6788460B2 (en) 1998-04-15 2004-09-07 Duke University Projection screen apparatus
US6829087B2 (en) 1998-04-15 2004-12-07 Bright View Technologies, Inc. Micro-lens array based light transmitting screen with tunable gain
US6816306B2 (en) 1998-04-15 2004-11-09 Bright View Technologies Inc. Micro-lens array based light transmitting screen with high resolution and low imaging artifacts
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
HUE026162T2 (en) 2007-02-07 2016-05-30 Novartis Ag Olopatadine preparation for topical nasal administration
PT2453872E (pt) * 2009-07-17 2013-10-30 Alcon Res Ltd Regime de pulverização nasal de olopatadina para crianças
WO2011027322A1 (en) 2009-09-03 2011-03-10 Ranbaxy Laboratories Limited Extended release dosage form containing olopatadine for oral administration
GB2485604A (en) * 2010-11-22 2012-05-23 Martin Chard Device for marking a surface
US9937189B2 (en) * 2013-09-13 2018-04-10 Glenmark Specialty S.A. Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
US9370483B2 (en) 2013-09-13 2016-06-21 Glenmark Specialty S.A. Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
ES2891729T3 (es) 2013-09-13 2022-01-31 Glenmark Specialty Sa Composición farmacéutica estable de dosis fija que comprende mometasona y olopatadina para la administración nasal
US10548907B2 (en) 2013-10-04 2020-02-04 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10016443B2 (en) 2013-10-04 2018-07-10 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
RU2686670C2 (ru) 2013-10-04 2019-04-30 Гленмарк Спешиалити С.А. Лечение аллергического ринита с использованием комбинации мометазона и олопатадина
US10758550B2 (en) 2013-10-04 2020-09-01 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10653661B2 (en) 2013-10-04 2020-05-19 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
CN104063850B (zh) * 2014-06-24 2017-02-01 广东互维科技有限公司 红眼修复方法
US11679210B2 (en) 2014-10-03 2023-06-20 Glenmark Specialty S.A. Dispensing device and pharmaceutical composition for the treatment of rhinitis
CN107569454B (zh) * 2017-09-29 2018-05-04 深圳大佛药业股份有限公司 一种盐酸奥洛他定鼻喷雾剂及其制备方法
US12303635B2 (en) 2018-04-16 2025-05-20 Glenmark Specialty S.A. Dispensing device and pharmaceutical composition for the treatment of rhinitis
US11890409B1 (en) * 2019-11-19 2024-02-06 Saeed Rezakhany Methods of curing early stages of, and preventing, upper respiratory infections and applicators therefor
USD969992S1 (en) * 2020-12-23 2022-11-15 Aptar France Sas Device for nasal spray
CN119677523A (zh) * 2022-03-02 2025-03-21 V·杜加尔 一种用于保护和治疗粘膜的过氧化氢治疗喷雾剂

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (enExample) * 1956-03-21 1900-01-01
US4923892A (en) * 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
GB8520662D0 (en) * 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
DE3882614T2 (de) * 1987-08-13 1993-11-18 Glaxo Group Ltd Indol-Derivate.
JPH0323237U (enExample) * 1989-07-19 1991-03-11
US5641805A (en) * 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
FR2803612B1 (fr) * 2000-01-12 2002-12-06 Michel Jean Louis Mar Doustaly Point d'eau sanitaire adaptable a une cuvette de wc
GB0014892D0 (en) * 2000-06-16 2000-08-09 Glaxo Group Ltd Novel pharmaceutical formulation
IT1317998B1 (it) * 2000-06-26 2003-07-21 Medical Internat Licensing N V Valvola erogatrice per spray nasale.
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US20040235955A1 (en) * 2001-09-14 2004-11-25 Masami Narita Remedies for pruritus
CN1297275C (zh) * 2002-11-12 2007-01-31 爱尔康公司 抗过敏剂和类固醇用于治疗过敏性鼻炎的用途
US7812120B2 (en) * 2003-03-21 2010-10-12 Par Pharmaceutical, Inc. Nasal calcitonin formulations containing chlorobutanol

Similar Documents

Publication Publication Date Title
JP2008521488A5 (enExample)
CY1110528T1 (el) Μεθοδος χορηγησης ρινικου εκνεφωματος
JP2007513959A5 (enExample)
HRP20192114T1 (hr) Deuterirani derivati ivakaftora
JP2007106777A5 (enExample)
JP2012500090A5 (enExample)
WO2006014930A3 (en) Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
JP2011229710A5 (enExample)
CN104830185A (zh) 一种除甲醛环保水性内墙涂料
RU2016118802A (ru) Наносимый распылением перевязочный материал для ожогов
JP2005503383A5 (enExample)
CN208492883U (zh) 一种便携式超声科用雾化器
CN207100593U (zh) 一种能适应各种脸型实现脸部完美贴合的口罩
CN207493028U (zh) 一种儿童雾化装置
CN204902029U (zh) 空气净化装置
CN205056350U (zh) 一种微网式超声雾化片装置
CN204106297U (zh) 防打鼾鼻腔塞
JP2004300103A5 (enExample)
CN217522869U (zh) 一种多功能手机壳
WO2022032468A8 (zh) 抗呼吸道病毒的装置、方法及药物
CN210149119U (zh) 一种小型车载雾化净化器
CN203469156U (zh) 便于放置的吸入式药物雾化器
JP2004513150A5 (enExample)
CN107960710A (zh) 一种带有定时喷药功能的医疗拐杖
CN202920985U (zh) 压力喷水鲸鱼玩具